3607 Parkway Ln Ste 200 Norcross, Georgia 30092
www.RayBiotech.com | info@raybiotech.com
770-729-2992 | +1-888-494-8555
ISO 13485:2016 cGMP
H1N1 Influenza-A Virus New Caledonia/20/99 IVR 116
Catalog #: 228-10163
Product Description
Specifications
| Size | 50 µg, 1000 µg |
| Estimated Lead Time | 2-3 weeks |
| Purity | Greater than 90.0% as determined by ELISA analysis. |
| Format | Sterile Filtered colorless solution FormulationThe H1N1 A/New Caledonia/20/99 IVR solution contains STE, 0.1 % sodium azide (NaN3) and 0.005 % thimerosal. |
| Recommended Applications | Tested with anti-influenza A monoclonal antibodies in ELISA.Serological studies of influenza A virus, immunogen for antibody production. |
| Research Area | Infectious Disease, Influenza |
| Shipping Type | Blue ice |
| Storage | -20°C |
Description
Description
Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/ New Caledonia/20/99 IVR 116. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient.
Inactivation
Thimerosal and beta propiolactone treatment. This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.
Stability & Storage
Storage/Stability
A/New Caledonia/20/99 IVR although stable 4°C for 4 weeks, should be stored desiccated below -18°C. Please prevent freeze-thaw cycles.